CYNDRX LLCDecember 18, 2025

FDA 483 - CYNDRX LLC - December 18, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore CYNDRX LLC

Record Details

An FDA inspection of CYNDRX LLC in Brentwood, TN, a specification developer, identified one significant observation related to inadequate design transfer procedures. The firm failed to establish documents ensuring that design control activities for its CyndRx AbsorbaSeal 5.6.7.F Vascular Closure Device were correctly translated into production specifications. This indicates a procedural lapse in ensuring product quality and regulatory compliance.

Company: CYNDRX LLC
Inspection Date: December 18, 2025
Product Type: Device
Office: New Orleans District Office
Person: Katlin N. Stubbs

Open in Dashboard

ID · 099b4108-b189-49a9-8a9e-362c7992335d